Oclaro Announces Intention To Offer $25M Of Exchangeable Senior Secured Second Lien Notes Due 2018

Oclaro

today announced that its wholly-owned subsidiary, Oclaro Luxembourg S.A. (the "Issuer"), has commenced a private offering, subject to market and other conditions, of approximately $25,000,000 in aggregate principal amount of Exchangeable Senior Secured Second Lien Notes due 2018 (the "Notes"), to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The Notes will be exchangeable into shares of common stock of the Company. The indenture governing the Notes will contain covenants restricting the Company's ability and the ability of certain subsidiaries of the Company to incur debt, make certain restricted payments, create liens, sell or dispose of certain assets and enter into certain mergers or corporate transactions. The Issuer's obligations under the Notes will be guaranteed by the Company and certain of its domestic and foreign subsidiaries, and will be secured by second priority liens on substantially all the tangible and intangible assets of the Company, the Issuer and the guarantors. The interest rate, exchange rate and other terms of the Notes will be determined at the time of the pricing of the offering. The Company intends to use the net proceeds of the offering for general corporate purposes, including working capital. In addition, the Company may use a portion of the net proceeds to acquire or invest in complementary businesses, products or technologies. The Company's management will have significant discretion in applying the net proceeds of the offering. This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale would be unlawful. The Notes, the guarantees and the shares of the Company's common stock issuable upon exchange of the Notes will not be registered under the Securities Act, or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration under the Securities Act or an applicable exemption from registration requirements.